CABA - Cabaletta Bio GAAP EPS of -$0.37 beats by $0.04
2023-11-09 07:57:29 ET
More on Cabaletta Bio
- Cabaletta Bio: How Long Can Unique Cell Therapy Developer's Sensational Bull Run Continue?
- Cantor starts Cabaletta at overweight, cites "strong" position in CART-T drugs
- Cabaletta Bio director purchases, sells shares in company
- Seeking Alpha’s Quant Rating on Cabaletta Bio
- Historical earnings data for Cabaletta Bio
For further details see:
Cabaletta Bio GAAP EPS of -$0.37 beats by $0.04